III. Mechanism

  1. Anesthetic spray distracts patient
  2. Clinician passively stretches Trigger PointMuscle

IV. Equipment: Vapocoolant Spray

  1. Fluori-Methane Spray (by Gebauer Co. in Cleveland)
  2. Contents of Vapocoolant Spray
    1. Dichlorodifluoromethane 15%
    2. Trichloromonofluoromethane 85%
  3. Spray kept at 10 to 12 degrees celsius

V. Technique

  1. Patient positioned comfortably
  2. Fluori-Methane sprayed over involved Muscle
    1. Direct spray at 30 to 60 degree angle
      1. Sweep spray parallel to Muscle fibers
      2. Sweep spray toward Trigger Point
    2. Spray 2-3 times, each covering 10 cm/sec
  3. Muscle involving Trigger Point is stretched
  4. After Stretch and Spray
    1. Apply moist heat to involved Muscle for 10-20 min
    2. Full active range of motion of involved Muscle
  5. Repeat up to daily for 1-2 weeks
  6. Suspend treatments for 2-3 days if soreness develops

VI. Precautions

  1. Hyperirritable Trigger Points may be exacerbated
  2. Fluori-Methane is potential biohazard for ozone loss
    1. Safer alternative than ethyl chloride (explosive)

VII. References

Images: Related links to external sites (from Bing)

Related Studies

Ontology: Physiatric stretching of fascia (C0203921)

Concepts Therapeutic or Preventive Procedure (T061)
SnomedCT 57443006
English Physiatric stretching of fascia, Physiatric stretching of fascia (regime/therapy), Physiatric stretching of fascia (procedure)
Spanish estiramiento fisiátrico de una fascia (procedimiento), estiramiento fisiátrico de una fascia (régimen/tratamiento), estiramiento fisiátrico de una fascia

Ontology: REFRIGERANT, TOPICAL (VAPOCOOLANT) (C0493876)

Concepts Medical Device (T074)
English REFRIGERANT, TOPICAL (VAPOCOOLANT)

Ontology: dichlorodifluoromethane / trichlorofluoromethane Topical Spray [fluori-methane] (C1235922)

Concepts Clinical Drug (T200)
English dichlorodifluoromethane / trichlorofluoromethane Topical Spray [fluori-methane]